Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): Insight into the failure of GIK

Diabetes and Vascular Disease Research

Volumn 4, Issue 3, 2007, Pages 222-225

  Parikh, Shailja V ^a   Abdullah, Shuaib M ^a,b   Keeley, Ellen C ^c   Cigarroa, Joaquin E ^d   Addo, Tayo A ^a   Warner, John J ^a   Khera, Amit ^a,b   De Lemos, James A ^a,b   McGuire, Darren K ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Biomarkers; Glucose insulin potassium; Insulin; Myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLUCOSE; INSULIN; POTASSIUM; TROPONIN T;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; GLUCOSE; HUMANS; INSULIN; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POTASSIUM; TIME FACTORS; TREATMENT FAILURE;

EID: 34948827952     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2007.043     Document Type: Article

References (18)

1. Sodi-Pallares D, Testelli MR, Fishleder BL et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962;9:166-81.
2. Marano L, Bestetti A, Lomuscio A et al. Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction. Acta Cardiol 2000;55:9-15.
3. Liu JG, Shu H, Shen FM et al. Effects of glucose-insulin-potassium on baroreflex sensitivity, left ventricular function and ventricular arrhythmia in the subacute phase of myocardial infarction in rats. Fundam Clin Pharmacol 2003;4:443-8.
4. Jonassen AK, Aasum E, Riemersma RA et al. Glucose-insulin- potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 2000;14:615-23.
5. Maroko PR, Libby P, Sobel BE et al. Effect of glucose-insulin- potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972;45:1160-75.
6. Addo TA, Keeley EC, Cigarroa JE et al. Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2004;10:1288-9.
7. Diaz R, Paolasso EA, Peigas LS et al. Metabolic modulation of acute myocardial infarction. The ELCA (Estudios Cardiologicos Latino-america) Collaborative Group. Circulation 1998;98:2227-34.
8. Van der Horst I, Zijlstra F, van't Hof A et al. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003;42:784-91.
9. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
10. Mehta SR, Yusuf S, Diaz R et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 2005;293:437-46.
11. Chaudhuri A, Janicke D, Wilson M et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004;109:849-54.
12. Dandona P, Mohanty P, Chaudhuri A et al. Insulin infusion in acute illness. J Clin Invest 2005;115:2068-72.
13. De Lemos J, Morrow D, Bentley J et al. The prognostic values of B type natriuretic peptide in patients with acute coronary syndrome. New Engl J Med 2001;345:1014-21.
14. Zhang HX, Zang YM, Huo JH et al. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 2006;48:306-13.
15. van der Horst IC, Ottervanger JP, van't Hof AW et al. The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction. BMC Med 2005;3:9.
16. Castro PF, Larrain C, Baeza R et al. Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med 2003;8:2152-5.
17. Redfield MM, Rodeheffer RJ, Jacobson SJ et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
18. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction - Executive Summary. Circulation 2004;110:588-636.